Hologic Panther Reagents CLE

The Department of Veterans Affairs Veterans Health Administration, specifically the Cleveland Veterans Affairs Medical Center (CLE VAMC), has published a Special Notice announcing its intent to sole source a procurement for Hologic Panther Reagents. This special notice was posted on December 3, 2025, and represents a sole source acquisition under FAR 13.106-1(b). The procurement is classified under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing) and PSC code 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits and Sets). The VA intends to negotiate exclusively with Hologic, located in Indianapolis, Indiana, based on the proprietary nature of the reagents and their unique compatibility with existing Panther instrumentation at the medical center.

The procurement objective is to acquire specialized in-vitro diagnostic reagents required to support women's health testing capabilities at CLE VAMC, including tests for chlamydia, gonorrhea, trichomonas, bacterial vaginosis, and yeast. Interested parties wishing to challenge the sole source determination must submit capability information to Rachelle Hamer by Wednesday, December 10, 2025, at 5 PM EST using the subject line "RFQ 36C25026Q0142| Hologic Panther Reagents." The small business size standard for this procurement is $41.5 million, and all inquiries must be submitted via email. While the VA has indicated its intent to sole source this requirement to Hologic based on the specialized and proprietary nature of the reagents, the government retains discretionary authority to open the requirement to full and open competition if warranted.